HER2 intratumoral heterogeneity analyses by concurrent HER2 gene and protein assessment for the prognosis of HER2 negative invasive breast cancer patients
Crossref DOI link: https://doi.org/10.1007/s10549-016-3856-2
Published Online: 2016-06-18
Published Print: 2016-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kurozumi, Sasagu
Padilla, Mary
Kurosumi, Masafumi
Matsumoto, Hiroshi
Inoue, Kenichi
Horiguchi, Jun
Takeyoshi, Izumi
Oyama, Tetsunari
Ranger-Moore, Jim
Allred, D. Craig
Dennis, Eslie
Nitta, Hiroaki
License valid from 2016-06-18